Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs.
Sign Up to like & getrecommendations! Published in 2021 at "Revista clinica espanola"
DOI: 10.1016/j.rceng.2021.05.008
Abstract: OBJECTIVE This work aims to analyze the impact of Spain's National Center for Cardiovascular Research (CNIC-Ferrer)'s cardiovascular (CV)-polypill on blood pressure (BP) and low-density lipoprotein cholesterol (cLDL) levels in patients in our healthcare area who… read more here.
Keywords: initiation; cardiovascular polypill; equally potent; polypill ... See more keywords